A detailed history of True Wealth Design, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, True Wealth Design, LLC holds 1,714 shares of MYGN stock, worth $10,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,714
Previous 598 186.62%
Holding current value
$10,832
Previous $5.31 Million 71.57%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

BUY
$3.84 - $8.84 $4,285 - $9,865
1,116 Added 186.62%
1,714 $9.1 Million
Q1 2025

May 13, 2025

BUY
$8.87 - $14.98 $4,257 - $7,190
480 Added 406.78%
598 $5.31 Million
Q4 2024

Feb 14, 2025

BUY
$13.17 - $27.03 $1,554 - $3,189
118 New
118 $1.62 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $510M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.